F. Hoffmann-La Roche Ltd (Manufacturing of medicinal product (including filling/primary packaging), in-process control testing, quality control testing for release and stability, except microscopic method for particle determination, storage of medicinal product, secondary packaging, release of finished medicinal product)

The drug is used to treat neovascular (exudative) age-related macular degeneration, diabetic macular edema, as well as macular edema caused by retinal vein occlusion (branch or central).

Dosage form: solution for injection

ATC: S01LA09